FCA
REGN icon

Florence Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Florence Capital Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4K Hold
11
– – ﹤0.01% 69
2017
Q3 		$5K Hold
11
– – 0.01% 64
2017
Q2 		$5K Hold
11
– – 0.02% 67
2017
Q1 		$4K Hold
11
– – 0.01% 71
2016
Q4 		$4K Buy
+11
New +$4.18K ﹤0.01% 69

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Florence Capital Advisors's REGN Position: Q4 2017 in Review

Florence Capital Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2017 at 11 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #69.

Florence Capital Advisors first reported a position in REGN in Q4 2016 and has held it in 5 quarters since. The position peaked at $5K in Q3 2017. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • Florence Capital Advisors held 11 shares of Regeneron Pharmaceuticals worth $4K as of Q4 2017.
  • Florence Capital Advisors left its Regeneron Pharmaceuticals share count unchanged in Q4 2017.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Florence Capital Advisors's portfolio in Q4 2017, its #69 holding.
  • Florence Capital Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • Florence Capital Advisors's Regeneron Pharmaceuticals position peaked at $5K in Q3 2017.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Florence Capital Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.